Mrs Deborah Ann Simmons, OTR/L | |
1777 Sportsman Rd, Felton, DE 19943-3870 | |
(302) 284-4177 | |
Not Available |
Full Name | Mrs Deborah Ann Simmons |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 1777 Sportsman Rd, Felton, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568460046 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | U1-0000176 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Deborah Ann Simmons, OTR/L 1777 Sportsman Rd, Felton, DE 19943-3870 Ph: (302) 284-4177 | Mrs Deborah Ann Simmons, OTR/L 1777 Sportsman Rd, Felton, DE 19943-3870 Ph: (302) 284-4177 |
News Archive
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) notified the companies that it will require a three-month extension to complete its review of the data supporting the New Drug Application (NDA) for linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC).
Health plan members who receive preventive health examinations, as opposed to going to a physician only when they are sick, appear more likely to undergo testing for colorectal, breast and prostate cancers, according to a report in the March 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Researchers from the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine have identified a key step required for cell division in a study that could help improve therapies to treat cancer.
The University HealthSystem Consortium, an alliance of 107 academic medical centers and 232 of their affiliated hospitals, announced today that the UHC/AACN Nurse Residency Programâ„¢ has helped members achieve an astounding 4.4% turnover rate among first-year nurses.
In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine, and 18 other centers around the U.S. and Poland have clarified the contribution of key cancer-associated genes, proteins and signaling pathways in these cancers, while proposing possible new treatment avenues.
› Verified 5 days ago